396 related articles for article (PubMed ID: 29648490)
41. Detailed analysis of CD4+ Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope.
Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC
J Immunol; 2002 Apr; 168(8):4001-11. PubMed ID: 11937557
[TBL] [Abstract][Full Text] [Related]
42. Expression of complete SIV p27 Gag and HIV gp120 engineered outer domains targeted by broadly neutralizing antibodies in live rubella vectors.
Virnik K; Nesti E; Dail C; Hockenbury M; Ni Y; Felber BK; Schief WR; Berkower I
Vaccine; 2017 May; 35(24):3272-3278. PubMed ID: 28483193
[TBL] [Abstract][Full Text] [Related]
43. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
44. Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques.
Smith JM; Amara RR; McClure HM; Patel M; Sharma S; Yi H; Chennareddi L; Herndon JG; Butera ST; Heneine W; Ellenberger DL; Parekh B; Earl PL; Wyatt LS; Moss B; Robinson HL
AIDS Res Hum Retroviruses; 2004 Jun; 20(6):654-65. PubMed ID: 15242543
[TBL] [Abstract][Full Text] [Related]
45. Activated CD4+CCR5+ T cells in the rectum predict increased SIV acquisition in SIVGag/Tat-vaccinated rhesus macaques.
Carnathan DG; Wetzel KS; Yu J; Lee ST; Johnson BA; Paiardini M; Yan J; Morrow MP; Sardesai NY; Weiner DB; Ertl HC; Silvestri G
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):518-23. PubMed ID: 25550504
[TBL] [Abstract][Full Text] [Related]
46. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
[TBL] [Abstract][Full Text] [Related]
47. Prior DNA immunization enhances immune response to dominant and subdominant viral epitopes induced by a fowlpox-based SIVmac vaccine in long-term slow-progressor macaques infected with SIVmac251.
Radaelli A; Nacsa J; Tsai WP; Edghill-Smith Y; Zanotto C; Elli V; Venzon D; Tryniszewska E; Markham P; Mazzara GP; Panicali D; De Giuli Morghen C; Franchini G
Virology; 2003 Jul; 312(1):181-95. PubMed ID: 12890631
[TBL] [Abstract][Full Text] [Related]
48. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
[TBL] [Abstract][Full Text] [Related]
49. Cytokine-induced augmentation of DNA vaccine-elicited SIV-specific immunity in rhesus monkeys.
Barouch DH; Letvin NL
Dev Biol (Basel); 2000; 104():85-92. PubMed ID: 11713828
[TBL] [Abstract][Full Text] [Related]
50. Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag/Env in outbred CD1 mice.
Andersson AC; Holst PJ
J Transl Med; 2016 Dec; 14(1):343. PubMed ID: 27998269
[TBL] [Abstract][Full Text] [Related]
51. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
[TBL] [Abstract][Full Text] [Related]
52. Vaccination with CTL epitopes that escape: an alternative approach to HIV vaccine development?
O'Connor D; Allen T; Watkins DI
Immunol Lett; 2001 Nov; 79(1-2):77-84. PubMed ID: 11595292
[TBL] [Abstract][Full Text] [Related]
53. Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection.
Allen TM; Jing P; Calore B; Horton H; O'Connor DH; Hanke T; Piekarczyk M; Ruddersdorf R; Mothé BR; Emerson C; Wilson N; Lifson JD; Belyakov IM; Berzofsky JA; Wang C; Allison DB; Montefiori DC; Desrosiers RC; Wolinsky S; Kunstman KJ; Altman JD; Sette A; McMichael AJ; Watkins DI
J Virol; 2002 Oct; 76(20):10507-11. PubMed ID: 12239328
[TBL] [Abstract][Full Text] [Related]
54. Dominant CD8+ T-lymphocyte responses suppress expansion of vaccine-elicited subdominant T lymphocytes in rhesus monkeys challenged with pathogenic simian-human immunodeficiency virus.
Manuel ER; Yeh WW; Seaman MS; Furr K; Lifton MA; Hulot SL; Autissier P; Letvin NL
J Virol; 2009 Oct; 83(19):10028-35. PubMed ID: 19641002
[TBL] [Abstract][Full Text] [Related]
55. Vaccination against endogenous retrotransposable element consensus sequences does not protect rhesus macaques from SIVsmE660 infection and replication.
Sheppard NC; Jones RB; Burwitz BJ; Nimityongskul FA; Newman LP; Buechler MB; Reed JS; Piaskowski SM; Weisgrau KL; Castrovinci PA; Wilson NA; Ostrowski MA; Park B; Nixon DF; Rakasz EG; Sacha JB
PLoS One; 2014; 9(3):e92012. PubMed ID: 24651676
[TBL] [Abstract][Full Text] [Related]
56. HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice.
Kulkarni V; Rosati M; Valentin A; Ganneru B; Singh AK; Yan J; Rolland M; Alicea C; Beach RK; Zhang GM; Le Gall S; Broderick KE; Sardesai NY; Heckerman D; Mothe B; Brander C; Weiner DB; Mullins JI; Pavlakis GN; Felber BK
PLoS One; 2013; 8(3):e60245. PubMed ID: 23555935
[TBL] [Abstract][Full Text] [Related]
57. Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine.
Chen SMY; Wong YC; Yim LY; Zhang H; Wang H; Lui GCY; Li X; Tang X; Cheng L; Du Y; Peng Q; Wang J; Kwok HY; Huang H; Lau TT; Chan DPC; Wong BCK; Liu L; Chakrabarti LA; Lee SS; Chen Z
J Virol; 2022 Apr; 96(7):e0216121. PubMed ID: 35297660
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses.
Qiu JT; Song R; Dettenhofer M; Tian C; August T; Felber BK; Pavlakis GN; Yu XF
J Virol; 1999 Nov; 73(11):9145-52. PubMed ID: 10516021
[TBL] [Abstract][Full Text] [Related]
59. Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques.
Dale CJ; Liu XS; De Rose R; Purcell DF; Anderson J; Xu Y; Leggatt GR; Frazer IH; Kent SJ
Virology; 2002 Sep; 301(1):176-87. PubMed ID: 12359458
[TBL] [Abstract][Full Text] [Related]
60. Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: efficacy and evolution of cytotoxic T lymphocyte escape in macaques.
Reece JC; Alcantara S; Gooneratne S; Jegaskanda S; Amaresena T; Fernandez CS; Laurie K; Hurt A; O'Connor SL; Harris M; Petravic J; Martyushev A; Grimm A; Davenport MP; Stambas J; De Rose R; Kent SJ
J Virol; 2013 Apr; 87(8):4146-60. PubMed ID: 23345519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
